IFP Advisors
HELP icon

IFP Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

IFP Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.46K Hold
200
– – ﹤0.01% 4135
2026
Q2 		$1.32K Hold
200
– – ﹤0.01% 4412
2026
Q1 		$960 Hold
200
– – ﹤0.01% 4230
2025
Q4 		$1.64K Hold
200
– – ﹤0.01% 3907
2025
Q3 		$1.18K Hold
200
– – ﹤0.01% 3895
2025
Q2 		$1.68K Hold
200
– – ﹤0.01% 3975
2025
Q1 		$1.27K Hold
200
– – ﹤0.01% 3284
2024
Q4 		$1.76K Buy
+200
New +$2.03K ﹤0.01% 3147

Other funds holding HELP

DA
DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Picton Mahoney Asset Management
Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Premier Fund Managers
Premier Fund Managers Guildford, United Kingdom $978M AUM 14.27% 1-Year Est. Return
ACPLP
ACT Capital Partners, L.P. Wayne, Pennsylvania $154M AUM
WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
PDS Planning
PDS Planning Dublin, Ohio $1.77B AUM 16.76% 1-Year Est. Return

IFP Advisors's HELP Position: Q3 2026 in Review

IFP Advisors held its Helus Pharma Inc. Common Stock (HELP) position steady in Q3 2026 at 200 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4135.

IFP Advisors first reported a position in HELP in Q4 2024 and has held it in 8 quarters since. 40 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

  • IFP Advisors held 200 shares of Helus Pharma Inc. Common Stock worth $2.46K as of Q3 2026.
  • IFP Advisors left its Helus Pharma Inc. Common Stock share count unchanged in Q3 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4135 holding.
  • IFP Advisors first reported a position in Helus Pharma Inc. Common Stock in Q4 2024 and has held it in 8 quarters since.
  • 40 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.